PATENT CLAIM ANALYSIS

Application Number: 16116411
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["514", "015400"]

Abstract:
The present disclosure provides compositions, kits, and methods to protect organs by inducing acquired cytoresistance without causing injury to the organ. The compositions, kits, and methods utilize heme proteins, iron and/or vitamin B12 and, optionally, agents that impact heme protein metabolism.

Claim (Index 18):
The method of  claim 12 , wherein the administration occurs at least 12 hours before the scheduled insult to the organ occurs.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 96.0
- Lexical Diversity: 1.42857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15030008', '15400690', '11123364', '15026574', '12690536']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7942466148408039
- 35 USC 102 Novelty (BERT): 0.6976252518877653
- Combined Prediction Score: 0.7845844785455002
- Mean Citation Score: 430.97484600000007
- Max Citation Score: 747.9826
- Similarity Product: 706.0355696427583

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test